Stay updated on Long-term Baricitinib in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Long-term Baricitinib in Atopic Dermatitis Clinical Trial page.

Latest updates to the Long-term Baricitinib in Atopic Dermatitis Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page now displays Revision: v3.5.4, replacing the previous v3.5.3. This reflects a small software update to the page.SummaryDifference0.0%

- Check24 days agoNo Change Detected
- Check39 days agoChange DetectedUpdates the displayed ClinicalTrials.gov page revision/build number from v3.5.2 to v3.5.3.SummaryDifference0.0%

- Check46 days agoChange DetectedAdded Moravian-Silesian Region and Nový Jičín (Moravian-Silesian Region, Czechia, 741 01); replaced Moravskoslezský kraj, Czechia, 741 01 with Moravian-Silesian Region entry; revision updated from 3.5.0 to 3.5.2.SummaryDifference0.0%

- Check68 days agoChange DetectedNapoli, Italy, 80131 was replaced with Naples, Italy, 80131 in the Locations list.SummaryDifference0.0%

- Check76 days agoChange DetectedUpdated page revision label from v3.4.3 to v3.5.0. No study content or results appear to be altered.SummaryDifference0.0%

- Check83 days agoChange DetectedRevision: v3.4.3 added and Revision: v3.4.2 removed.SummaryDifference0.0%

Stay in the know with updates to Long-term Baricitinib in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Long-term Baricitinib in Atopic Dermatitis Clinical Trial page.